Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects

I Nostri OrariLun. - Sab. 10:00-19:00 Chiamaci al+39 375 540 9488E-Mailallergy.dralbanesi@gmail.comViale Japigia, 131/DBariMiodottore.itSiamo anche qui

Nada Chaoul a Marcello Albanesi a Lucia Giliberti a Maria Pia Rossi a Eustachio Nettis a Danilo Di Bona Maria Filomena Caiaffa b Luigi Macchia a

previousThe interactions of therapeutic antibodies with Fc receptors

nextLong-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study

Dal 2020 sono Dirigente Medico al Policlinico di Bari nel Dipartimento d’Urgenza e Trapianti d’Organo e sono il fondatore dello studio Medico Allergologico “Albanesi” (che fantasia nel nome!)

Messaggi recenti

21 Aprile 2023
Telemedicina
3 Marzo 2022
Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study

Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects

Leave a Reply Cancel Reply

previousThe interactions of therapeutic antibodies with Fc receptors

nextLong-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study

Telemedicina

Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study

Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects

The interactions of therapeutic antibodies with Fc receptors

Association between autoimmune disease and cutaneous melanoma with regard to melanoma prognosis

Messaggi recenti

Telemedicina

Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study

Link Utili